SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-175530
Filing Date
2022-06-16
Accepted
2022-06-16 16:23:58
Documents
13
Period of Report
2022-06-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d315444d8k.htm   iXBRL 8-K 52139
2 EX-99.1 d315444dex991.htm EX-99.1 83869
  Complete submission text file 0001193125-22-175530.txt   284560

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sdgr-20220615.xsd EX-101.SCH 2870
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE sdgr-20220615_lab.xml EX-101.LAB 17996
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sdgr-20220615_pre.xml EX-101.PRE 11271
7 EXTRACTED XBRL INSTANCE DOCUMENT d315444d8k_htm.xml XML 3389
Mailing Address 1540 BROADWAY 24TH FLOOR NEW YORK NY 10036
Business Address 1540 BROADWAY 24TH FLOOR NEW YORK NY 10036 503-299-1150
Schrodinger, Inc. (Filer) CIK: 0001490978 (see all company filings)

IRS No.: 954284541 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39206 | Film No.: 221020874
SIC: 2834 Pharmaceutical Preparations